Camelia pharmacy chain has been acquired by Medigate Management UAB
CGP Management UAB has sold the Camelia pharmacy chain (UAB Nemuno vaistinė and subsidiaries) to Medigate Management UAB.
UAB Nemuno vaistinė, operating under the brand name Camelia, is the leading pharmacy chain in Lithuania. The group carries out retail and wholesale trade in pharmaceuticals, food supplements, medical devices and cosmetics. Camelia’s pharmacy chain includes a countrywide network of approximately 300 own and 30 franchise outlets and manages one of the leading online pharmacies in Lithuania. Besides pharmacy retail and wholesale, the group is also involved in the development of pharmaceutical and nutraceutical products under its own brand names (private label).
Medigate Management UAB is a private investment holding company owned by Mr. Petras Bartkus (a minority shareholder in Camelia before the transaction). Medigate Management owns UAB Medigate, a developer and wholesaler of food supplements, medical devices and cosmetics in Lithuania.
CGP Management UAB is a private holding company owned by the founder of the Camelia pharmacy chain.
Oaklins’ team in Lithuania acted as the sole financial advisor to CGP Management on the sale of the Camelia pharmacy chain to Medigate Management.
Talk to the deal team
Related deals
The Providence Projects has been acquired by UKAT Group
Celebrity-success rehabilitation center, The Providence Projects, has joined The UK Addiction Treatment (UKAT) Group, backed by Sullivan Street Equity Partners.
Learn moreSt. Claraspital AG has been acquired by University Hospital Basel
University Hospital Basel (USB) has acquired St. Claraspital AG, expanding its network of specialized care and integrated services. With St. Claraspital’s strong community presence, expertise in acute and rehabilitation medicine and established outpatient clinics, this merger enhances USB’s ability to provide seamless, patient-centered treatment across the continuum of care. The completion of the transaction is subject to clearance by the Swiss Competition Commission (COMCO).
Learn moreA share exchange agreement for making NARUMIYA a wholly owned subsidiary of World has been executed
World Co., Ltd. and NARUMIYA INTERNATIONAL Co., Ltd. have entered into a definitive share exchange agreement, under which World will acquire all outstanding shares of NARUMIYA and make it a wholly owned subsidiary. The share exchange is scheduled to take effect on 1 October 2025. Under the terms of the agreement, NARUMIYA shareholders will receive 0.58 shares of World stock for each Narumiya share they hold.
Learn more